Melucci
Melucci v. Corcept Therapeutics Incorporated
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN JOSE DIVISION
FERRARO FAMILY FOUNDATION, INC. Case No. 19-CV-01372-LHK and JAMES L. FERRARO, on behalf of themselves and all others similarly situated,
ORDER GRANTING IN PART AND
Plaintiffs, DENYING IN PART DEFENDANTS’
MOTION TO DISMISS PLAINTIFFS’
v. THIRD AMENDED COMPLANT
CORCEPT THERAPEUTICS
INCORPORATED, JOSEPH K.
BELANOFF, CHARLES ROBB, and SEAN
MADUCK,
18 Defendants. 19 This case is a putative securities class action against Corcept Therapeutics Incorporated (“Corcept”); its Chief Executive Officer, Joseph K. Belanoff; its Chief Financial Officer, Charles Robb; and its Vice President of Commercial Sean Maduck (collectively, “Defendants”). Lead Plaintiff Ferraro Family Foundation, Inc. and James L. Ferraro (“Plaintiffs”) bring this suit on behalf of “all other persons similarly situated who purchased or otherwise acquired Corcept securities between August 2, 2017 and January 31, 2019, inclusive (the ‘Class Period’).” Third…